President Trump said Wednesday that starting August 1, imported generic drugs will face a 0% tariff for two years, rising to 100% for one year and then 200%, according to N12. The measure is designed to bring generic drug manufacturing back to the United States by penalizing companies that do not build factories within the allotted time.
President Trump announced a new phased tariff on all imported generic drugs, according to N12. The plan will take effect August 1, with a 0% tariff for two years, then 100% for one year, and finally 200% thereafter. The policy aims to reshore generic drug manufacturing and penalize companies that fail to build production facilities in the United States within the given timeframe.
Trump has previously threatened tariffs on European countries over digital services taxes and imposed a 50% tariff on Canadian goods, as The Zioneer has reported. The generic drug tariff represents a significant escalation in trade policy targeting the pharmaceutical sector.
2 developments
- StrongTrump renews threat of 100% tariff on European countries over digital services tax
- StrongUS details 50% tariff on Canadian wine, cement, hockey gear, citing 100-year-old law
- DevelopingFederal appeals court lets Trump's 10% tariff stand during appeal
- DevelopingTrump: Taiwan took 100% of semiconductor business, moving it back to US
Source and signal
A single-sourced dispatch is never rated Confirmed or Strong. Its Signal strengthens only when a second, independent source corroborates it.
- Internal intake